pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2022-32-3-448-472pulmo-4110Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL GUIDELINESХронический бронхит: федеральные клинические рекомендации по диагностике и лечениюFederal guidelines on diagnosis and treatment of chronic bronchitishttps://orcid.org/0000-0002-5999-2150АвдеевС. Н.AvdeevS. N.

д. м. н., профессор, академик Российской академии наук, заведующий кафедрой пульмонологии Института клинической медицины имени Н.В.Склифосовского, 119991, Москва, ул. Трубецкая, 8, стр. 2;

ведущий научный сотрудник, 115682, Москва, Ореховый бульвар, 28

Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, Head of the Department of Pulmonology, N.V.Sklifosovsky Institute of Clinical Medicine, ul. Trubetskaya 8, build. 2, Moscow, 119991;

Leading Researcher, Orehovyy bul’var 28, Moscow, 115682

serg_avdeev@list.ruhttps://orcid.org/0000-0001-8982-5292ДемкоИ. В.DemkoI. V.

д. м. н., профессор, заведующая кафедрой внутренних болезней № 2 с курсом постдипломного образования,

660022, Красноярск, ул. Партизана Железняка, 1

Doctor of Medicine, Professor, Head of Department of Internal Medicine No.2 with Postgraduate Physician Training Course, 

ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022

demko64@mail.ruhttps://orcid.org/0000-0002-0934-7313ЗайцевА. А.ZaytsevA. A.

д. м. н., профессор, главный пульмонолог,

105094, Москва, Госпитальная пл., 3

Doctor of Medicine, Professor, Chief Pulmonologist,

Gospital’naya pl. 3, Moscow, 105229

a-zaicev@yandex.ruhttps://orcid.org/0000-0002-0877-6554ИгнатоваГ. Л.IgnatovaG. L.

д. м. н., профессор, заведующая кафедрой терапии Института дополнительного профессионального образования, 454092, Челябинск, ул. Воровского, 64;

руководитель Городского пульмонологического центра (Челябинск), главный пульмонолог Челябинска

Doctor of Medicine, Professor, Head of Department of Therapy, Institute of Postgraduate Physician Training,

ul. Vorovskogo 64, Chelyabinsk, 454092

iglign@mail.ruКравченкоН. Ю.KravchenkoN. Yu.

руководитель научно-методического центра мониторинга и контроля болезней органов дыхания , 115682, Москва, Ореховый бульвар, 28;

заведующая центром респираторной медицины, 105077, Москва, ул. 11-я Парковая, 32

Head of the Scientific and Methodological Center for Monitoring and Control of Respiratory Diseases, Orehovyy bul’var 28, Moscow, 115682;

Head of Respiratory Medicine Center, ul. Odinnadtsataya Parkovaya 32, Moscow, 105077

pulmokongress@mail.ruhttps://orcid.org/0000-0002-1620-7159ЛещенкоИ. В.LeshchenkoI. V.

д. м. н., профессор кафедры фтизиатрии и пульмонологии, 620028, Екатеринбург, ул. Репина, 3;

главный научный сотрудник, 620039, Свердловская область, Екатеринбург, 22-го Партсъезда, 50

Doctor of Medicine, Professor, Department of Phthisiology and Pulmonology, ul. Repina 3, Ekaterinburg, 620028;

Chief Researcher, ul. 22-go Parts’ezda 50, Ekaterinburg, 620039

leshchenkoiv@yandex.ruОвчаренкоС. И.OvcharenkoS. I.

д. м. н., профессор кафедры факультетской терапии № 1,

119991, Москва, ул. Трубецкая, 8, стр. 2

Doctor of Medicine, Professor, Department No.1 of General Internal Medicine,

ul. Trubetskaya 8, build. 2, Moscow, 119991

svetftk@mail.ruhttps://orcid.org/0000-0002-1990-2042СинопальниковА. И.Sinopal’nikovA. I.

д. м. н., профессор, заведующий кафедрой пульмонологии,

125993, Москва, ул. Баррикадная, 2 / 1, стр. 1

Doctor of Medicine, Professor, Head of Department of Pulmonology, 

ul. Barrikadnaya 2/1, build. 1, Moscow, 123995

aisyn@list.ruhttps://orcid.org/0000-0003-1604-3446ФранцузевичЛ. Я.FrantsuzevichL. Ya.

врач-пульмонолог, 115522, Москва, Каширское шоссе, 34А;

стажер-исследователь отдела внутренних болезней Медицинского научно-образовательного центра, 119991, Москва, Ленинские горы, 1;

ассистент кафедры пульмонологии факультета дополнительного профессионального образования, 117997, Москва, ул. Островитянова, 1

Pulmonologist, Kashirskoe shosse 34A, Moscow, 115522;

Intern Researcher, Department of Internal Medicine, Medical Research and Education Center, Leninskie gory 1, Moscow, 119991;

Assistant Lecturer, Department of Pulmonology, ul. Ostrovityanova 1, Moscow, 117997

frantsuzevitch@mail.ruФедеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет имени И.М.Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет); Федеральное государственное бюджетное учреждение «Научно-исследовательский институт пульмонологии» Федерального медико-биологического агентстваРоссияFederal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Federal Pulmonology Research Institute, Federal Medical and Biological Agency of RussiaRussian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Красноярский государственный медицинский университет имени профессора В.Ф.Войно-Ясенецкого» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Higher Education “Prof. V.F.Voino-Yasenetsky Krasnoyarsk State Medical University”, Ministry of Healthcare of the Russian FederationRussian FederationФедеральное государственное бюджетное учреждение «Главный военный клинический госпиталь имени академика Н.Н.Бурденко» Министерства обороны Российской ФедерацииРоссияMain Military Clinical Hospital named after academician N.N.Burdenko, Ministry of Defense of the Russian FederationRussian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSouth Ural State Medical University, Healthcare Ministry of RussiaRussian FederationФедеральное государственное бюджетное учреждение «Научно-исследовательский институт пульмонологии» Федерального медико-биологического агентства; Государственное бюджетное учреждение здравоохранения города Москвы «Городская клиническая больница имени Д.Д.Плетнева Департамента здравоохранения города Москвы»РоссияFederal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia$ State Budgetary City Teaching Hospital “City Clinical Hospital named after D.D.Pletnev of Healthcare Moscow City Department”Russian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации; Уральский научно-исследовательский институт фтизиопульмонологии – филиал федерального государственного бюджетного учреждения «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний» Министерства здравоохранения Российской ФедерацииРоссияFederal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation; Ural Federal Research Institute of Phthisiology and Pulmonology – A Branch of National Medical Research Center for Phthisiology, Pulmonology and Infectious Diseases, Healthcare Ministry of RussiaRussian FederationФедеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет имени И.М.Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияFederal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)Russian FederationФедеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской ФедерацииРоссияRussian Medical Academy of Continuous Professional Education, Healthcare Ministry of Russian FederationRussian FederationФедеральное государственное бюджетное научное учреждение «Научно-исследовательский институт ревматологии имени В.А.Насоновой»; Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный университет имени М.В.Ломоносова»; Федеральное государственное автономное образовательное учреждение высшего образования «Российский национальный исследовательский медицинский университет имени Н.И.Пирогова» Министерства здравоохранения Российской ФедерацииРоссияV.A.Nasonova Federal Research Rheumatology Institute; Federal State Budget Educational Institution of Higher Education M.V.Lomonosov Moscow State University; Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of the Russian FederationRussian Federation202214072022323Спецвыпуск448472Copyright © Авдеев С.Н., Демко И.В., Зайцев А.А., Игнатова Г.Л., Кравченко Н.Ю., Лещенко И.В., Овчаренко С.И., Синопальников А.И., Французевич Л.Я., 20222022Авдеев С.Н., Демко И.В., Зайцев А.А., Игнатова Г.Л., Кравченко Н.Ю., Лещенко И.В., Овчаренко С.И., Синопальников А.И., Французевич Л.Я.Avdeev S.N., Demko I.V., Zaytsev A.A., Ignatova G.L., Kravchenko N.Y., Leshchenko I.V., Ovcharenko S.I., Sinopal’nikov A.I., Frantsuzevich L.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/4110

Представлены современные сведения об этиологии и патогенезе, клинических проявлениях, диагностике и лечении хронического бронхита.

Методология

Методология. Целевой аудиторией данных клинических рекомендаций являются врачи общей практики, врачи-терапевты и врачи-пульмонологи. Каждый тезис-рекомендация по проведению диагностических и лечебных мероприятий оценивается по шкалам уровней достоверности доказательств от 1 до 5 и шкале оценки уровней убедительности рекомендаций по категориям А, В, С. Клинические рекомендации содержат также комментарии и разъяснения к указанным тезисам-рекомендациям, алгоритм ведения пациентов с установленным диагнозом хронический бронхит.

Заключение

Заключение. Представленные клинические рекомендации по диагностике и лечению хронического бронхита одобрены Научно-практическим советом Министерства здравоохранения Российской Федерации (2021). 

The presented clinical guidelines cover current information about the etiology and pathogenesis, classification, clinical manifestations, diagnosis, treatment, and prevention of chronic bronchitis.

Methodology

Methodology. The target audience of these clinical guidelines are therapists, general practitioners, and pulmonologists. Each thesis-recommendation about diagnostic and therapeutic procedures has been graded according to the scales of classes of recommendations from 1 to 5 and the A, B, C scale for the levels of evidence. The clinical guidelines also contain comments and explanations to these theses together with an algorithm for management of patients with confirmed chronic bronchitis.

Conclusion

Conclusion. The presented clinical guidelines for the diagnosis and treatment of chronic bronchitis were approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation in 2021. 

хронический бронхитобострение бронхитакашелькурениемуколитическая терапияchronic bronchitisexacerbation of bronchitiscoughsmokingmucolytic therapyReferencesDefinition and classification of chronic bronchitis for clinical and epidemiological purposes: A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet. 1965; 1 (7389): 775–779. DOI: 10.1016/S0140-6736(65)92953-3.Definition and classification of chronic bronchitis for clinical and epidemiological purposes: A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet. 1965; 1 (7389): 775-779. https://doi.org/10.1016/S0140-6736(65)92953-3.Brаman S.S. Chronic cough due to chronic bronchitis: ACCP Evidence-Based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 104S–115S. DOI: 10.1378/chest.129.1_suppl.104S.Braman S.S. Chronic cough due to chronic bronchitis: ACCP Evidence-Based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 104S-115S. https://doi.org/10.1378/chest.129.1_suppl.104S.Черняев А.Л. Патоморфология хронического обструктивного бронхита. Русский медицинский журнал. 1997; (17): 3–10. Доступно на: https://www.rmj.ru/articles/obshchie-stati/PATOMORFOLOGIYa_HRONIChESKOGO_OBSTRUKTIVNOGO_BRONHITA/Chernyaev A.L. [Pathomorphology of chronic obstructive bronchitis]. Russkiy meditsinskiy zhurnal. 1997; (17): 3-10. Available at: https://www.rmj.ru/articles/obshchie-stati/PATOMORFOLOGIYa_HRONIChESKOGO_OBSTRUKTIVNOGO_BRONHITA (in Russian).Pallasaho P., Lundback B., Laspa S.L. et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir. Med. 1999; 93 (11): 798–809. DOI: 10.1016/s0954-6111(99)90265-2.Pallasaho P., Lundback B., Laspa S.L. et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir. Med. 1999; 93 (11): 798-809. https://doi.org/10.1016/s0954-6111(99)90265-2.Sobradillo V., Miravitlles M., Jimenez C.A. et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch. Bronconeumol. 1999; 35 (4): 159–166. DOI: 10.1016/s0300-2896(15)30272-6.Sobradillo V., Miravitlles M., Jimenez C.A. et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch. Bronconeumol. 1999; 35 (4): 159-166. https://doi.org/10.1016/s0300-2896(15)30272-6.Cerveri I., Accordini S., Verlato G. et al. European community respiratory health survey (ECRHS) study group. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur. Respir. J. 2001; 18 (1): 85–92. DOI: 10.1183/09031936.01.00087101.Cerveri I., Accordini S., Verlato G. et al. European community respiratory health survey (ECRHS) study group. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur. Respir. J. 2001; 18 (1): 85-92. https://doi.org/10.1183/09031936.01.00087101.Janson C., Chinn S., Jarvis D., Burney P. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur. Respir. J. 2001; 18 (4): 647–654. DOI: 10.1183/09031936.01.00098701.Janson C., Chinn S., Jarvis D., Burney P. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur. Respir. J. 2001; 18 (4): 647-654. https://doi.org/10.1183/09031936.01.00098701.Huchon G.J., Vergnenegre A., Neukirch F. et al. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur. Respir. J. 2002; 20 (4): 806–812. DOI: 10.1183/09031936.02.00042002.Huchon G.J., Vergnenegre A., Neukirch F. et al. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur. Respir. J. 2002; 20 (4): 806-812. https://doi.org/10.1183/09031936.02.00042002.Miravitlles M., de la Roza C., Morera J. et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir. Med. 2006; 100 (11): 1973–1980. DOI: 10.1016/j.rmed.2006.02.024.Miravitlles M., de la Roza C., Morera J. et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir. Med. 2006; 100 (11): 1973-1980. https://doi.org/10.1016/j.rmed.2006.02.024.Pelkonen M., Notkola I.L., Nissinen A. et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006; 130 (4): 1129–1137. DOI: 10.1378/chest.130.4.1129.Pelkonen M., Notkola I.L., Nissinen A. et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006; 130 (4): 1129-1137. https://doi.org/10.1378/chest.130.4.1129.de Marco R., Accordini S., Cerveri I. et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am. J. Respir. Crit. Care Med. 2007; 175 (1): 32–39. DOI: 10.1164/rccm.200603-381OC.de Marco R., Accordini S., Cerveri I. et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am. J. Respir. Crit. Care Med. 2007; 175 (1): 32-39. https://doi.org/10.1164/rccm.200603-381OC.Miravitlles M., Soriano J.B., Garcia-Rio F. et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64 (10): 863–868. DOI: 10.1136/thx.2009.115725.Miravitlles M., Soriano J.B., Garcia-Rio F. et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64 (10): 863-868. https://doi.org/10.1136/thx.2009.115725.Martinez C., Chen Y., Kazerooni E. et al. Non-obstructive chronic bronchitis in the COPDGene cohort. Am. J. Respir. Crit. Care Med. 2012; 185: 6622. DOI: 10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6622.Martinez C., Chen Y., Kazerooni E. et al. Non-obstructive chronic bronchitis in the COPDGene cohort. Am. J. Respir. Crit. Care Med. 2012; 185: 6622. https://doi.org/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6622.Косарев В.В., Бабанов С.А. Социальные аспекты хронического бронхита по данным эпидемиологического исследования. Экология человека. 2005; (12): 46–49. Доступно на: https://cyberleninka.ru/article/n/sotsialnye-aspekty-hronicheskogo-bronhita-po-dannym-epidemiologicheskogo-issledovaniya/viewer.Kosarev V.V., Babanov S.A. [Social aspects of chronic bronchitis according to an epidemiological study]. Ekologiya cheloveka. 2005; (12): 46-49. Dostupno na: https://cyberleninka.ru/article/n/sotsialnye-aspekty-hronicheskogo-bronhita-po-dannym-epidemiologicheskogo-issledovaniya/viewer (in Russian).Международная классификация болезней 10-го пересмотра. Доступно на: https://mkb-10.com/International classification of diseases of the 10th revision. Available at: https://mkb-10.com (in Russian).Smith J.A., Woodcock A. Chronic cough. N. Engl. J. Med. 2016; 375 (16): 1544–1551. DOI: 10.1056/NEJMcp1414215.Smith J.A., Woodcock A. Chronic cough. N. Engl. J. Med. 2016; 375 (16): 1544-1551. https://doi.org/10.1056/NEJMcp1414215.Terasaki G., Paauw D.S. Evaluation and treatment of chronic cough. Med. Clin. N. Am. 2014; 98 (3): 391–403. DOI: 10.1016/j.mcna.2014.01.002.Terasaki G., Paauw D.S. Evaluation and treatment of chronic cough. Med. Clin. N. Am. 2014; 98 (3): 391-403. https://doi.org/10.1016/j.mcna.2014.01.002.Achilleos A. Evidence-based evaluation and management of chronic cough. Med. Clin. North Am. 2016; 100 (5): 1033–1045. DOI: 10.1016/j.mcna.2016.04.008Achilleos A. Evidence-based evaluation and management of chronic cough. Med. Clin. North Am. 2016; 100 (5): 1033-1045. https://doi.org/10.1016/j.mcna.2016.04.008Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2020 Report. Available at: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINALver1.2-03Dec19_WMV.pdfGlobal Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2020 Report. Available at: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdfDicpinigaitis P.V. Angiotensin-converting enzyme inhibitor-induced cough:ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 169S–173S. DOI: 10.1378/chest.129.1_suppl.169S.Dicpinigaitis P.V. Angiotensin-converting enzyme inhibitor-induced cough:ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 169S-173S. https://doi.org/10.1378/chest.129.1_suppl.169S.Pratter M.R. Overview of common causes of chronic cough. ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 59S–62S. DOI: 10.1378/chest.129.1_suppl.59S.Pratter M.R. Overview of common causes of chronic cough. ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 59S-62S. https://doi.org/10.1378/chest.129.1_suppl.59S.Braman S.S. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 104S–115S. DOI: 10.1378/chest.129.1_suppl.104S.Braman S.S. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 104S-115S. https://doi.org/10.1378/chest.129.1_suppl.104S.Celli B., MacNee W., ATS/ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur. Respir. J. 2004; 23 (6): 932–946. DOI: 10.1183/09031936.04.00014304.Celli B., MacNee W., ATS/ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur. Respir. J. 2004; 23 (6): 932-946. https://doi.org/10.1183/09031936.04.00014304.Синопальников А.И., Клячкина И.Л. Кашель: Карманные рекомендации. М.: Ремедиум; 2013.Sinopal’nikov A.I., Klyachkina I.L. [Cough: Recommendations]. Moscow: Remedium; 2013 (in Russian).Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106 (2): 196–204. DOI: 10.7326/0003-4819-106-2-196.Anthonisen N.R., Manfreda J., Warren C.P. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106 (2): 196-204. https://doi.org/10.7326/0003-4819-106-2-196.Feeney A. S., Fendrick A. M., Quintiliani R. Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am. J. Manag. Care. 2004; 10 (10): 689–696. Available at: https://www.ajmc.com/view/oct04-1903p689-696Feeney A. S., Fendrick A. M., Quintiliani R. Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am. J. Manag. Care. 2004; 10 (10): 689-696. Available at: https://www.ajmc.com/view/oct04-1903p689-696Irwin R.S., French C.I., Chang A.B.et. al. Classification of cough as a symptom in adults and management algorithms. CHEST Guideline and Expert Panel Report. Chest. 2018; 153 (1): 196–209. DOI: 10.1016/j.chest.2017.10.016.Irwin R.S., French C.I., Chang A.B. et. al. Classification of cough as a symptom in adults and management algorithms. CHEST Guideline and Expert Panel Report. Chest. 2018; 153 (1): 196-209. https://doi.org/10.1016/j.chest.2017.10.016.Шепеленко А.Ф. Хронический бронхит. Трудный пациент. 2009; 7 (3): 33–38. Доступно на: https://cyberleninka.ru/article/n/hronicheskiy-bronhit/viewer.Shepelenko A.F. [Chronical bronchitis]. Trudnyy patsient. 2009; 7 (3): 33-38. Available at: https://cyberleninka.ru/article/n/hronicheskiy-bronhit/viewer (in Russian).Woodhead M., Blasi F., Ewig S. et al. Guidelines for the management of adult lover respiratory tract infections. Clin. Microbiol. Infect. 2011; 17 (Suppl. 6): 1–24. DOI: 10.1111/j.1469-0691.2011.03602.x.Woodhead M., Blasi F., Ewig S. et al. Guidelines for the management of adult lover respiratory tract infections. Clin. Microbiol. Infect. 2011; 17 (Suppl. 6): 1-24. https://doi.org/10.1111/j.1469-0691.2011.03602.x.Weis N., Almdal T. C-reactive protein – can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2006; 17 (2): 88-91. DOI: 10.1016/j.ejim.2005.09.020.Weis N., Almdal T. C-reactive protein - can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease. Eur. J. Intern. Med. 2006; 17 (2): 88-91. https://doi.org/10.1016/j.ejim.2005.09.020.Amalakanti S., Pentakota M. R. Pulse oximetry overestimates oxygen saturation in COPD. Respir. Care. 2016; 61 (4): 423–427. DOI: 10.4187/respcare.04435.Amalakanti S., Pentakota M. R. Pulse oximetry overestimates oxygen saturation in COPD. Respir. Care. 2016; 61 (4): 423-427. https://doi.org/10.4187/respcare.04435.Dev D., Sankaran E.W.R., Cunnife J. et al. Value of C-reactive protein in exacerbation of chronic obstructive pulmonary disease. Respir. Med. 1998; 92 (4): 664–667. DOI: 10.1016/s0954-6111(98)90515-7.Dev D., Sankaran E.W.R., Cunnife J. et al. Value of C-reactive protein in exacerbation of chronic obstructive pulmonary disease. Respir. Med. 1998; 92 (4): 664-667. https://doi.org/10.1016/s0954-6111(98)90515-7.Wielpütz M.O., Heußel C.P., Herth F.J., Kauczor H.U. Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality. Dtsch. Arztebl. Int. 2014; 111 (11): 181. DOI: 10.3238/arztebl.2014.0181.Wielpütz M.O., Heußel C.P., Herth F.J., Kauczor H.U. Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality. Dtsch. Arztebl. Int. 2014; 111 (11): 181. https://doi.org/10.3238/arztebl.2014.0181.Agarwal R. L., Kumar D., Agarwal D.K.; Chabra G.S. Diagnostic values of electrocardiogram in chronic obstructive pulmonary disease (COPD). Lung India. 2008; 25 (2): 78. DOI: 10.4103/0970-2113.44125.Agarwal R. L., Kumar D., Agarwal D.K.; Chabra G.S. Diagnostic values of electrocardiogram in chronic obstructive pulmonary disease (COPD). Lung India. 2008; 25 (2): 78. https://doi.org/10.4103/0970-2113.44125.Chen M., Chen P., Zhong N. et al. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chinese Med. J. 2011; 124 (20): 3207–3219. DOI: 10.3760/cma.j.issn.0366-6999.2011.20.002.Chen M., Chen P., Zhong N. et al. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chinese Med. J. 2011; 124 (20): 3207-3219. https://doi.org/10.3760/cma.j.issn.0366-6999.2011.20.002.Lai K., Shen H., Zhou X. et al. Clinical practice guidelines for diagnosis and management of cough: Chinese Thoracic Society (CTS) asthma consortium. J. Thorac. Dis. 2018; 10 (11): 6314–6351. DOI: 10.21037/jtd.2018.09.153.Lai K., Shen H., Zhou X. et al. Clinical practice guidelines for diagnosis and management of cough: Chinese Thoracic Society (CTS) asthma consortium. J. Thorac. Dis. 2018; 10 (11): 6314-6351. https://doi.org/10.21037/jtd.2018.09.153.Irwin R.S. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 80S–94S. DOI: 10.1378/chest.129.1_suppl.80S.Irwin R.S. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (1, Suppl.): 80S-94S. https://doi.org/10.1378/chest.129.1_suppl.80S.Hukkinen M., Korhonen T., Broms U. et al. Long-Term smoking behavior patterns predicting self-reported chronic bronchitis. J. COPD. 2009; 6 (4): 242–249. DOI: 10.1080/15412550903051781.Hukkinen M., Korhonen T., Broms U. et al. Long-Term smoking behavior patterns predicting self-reported chronic bronchitis. J. COPD. 2009; 6 (4): 242-249. https://doi.org/10.1080/15412550903051781.Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Cur. Opin. Pulm. Med. 2008; 14 (2): 105–109. DOI: 10.1097/MCP.0b013e3282f379e9.Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Cur. Opin. Pulm. Med. 2008; 14 (2): 105-109. https://doi.org/10.1097/MCP.0b013e3282f379e9.Wynder E., Kaufman P., Lerrer R. et al. A short term follow up study on ex-cigarette smokers: with special emphasis on persistent cough and weight gain. Am. Rev. Respir. Dis. 1967; 96 (4): 645–655. DOI: 10.1164/arrd.1967.96.4.645.Wynder E., Kaufman P., Lerrer R. et al. A short term follow up study on ex-cigarette smokers: with special emphasis on persistent cough and weight gain. Am. Rev. Respir. Dis. 1967; 96 (4): 645-655. https://doi.org/10.1164/arrd.1967.96.4.645.Chandler M.A., Rennard S.I. Smoking cessation. Chest. 2010; 137 (2): 428–435. DOI: 10.1378/chest.09-0124.Chandler M.A., Rennard S.I. Smoking cessation. Chest. 2010; 137 (2): 428-435. https://doi.org/10.1378/chest.09-0124.Jorenby D.E., Leischow S.J., Nides M.A. et al. A controlled trial of sustained- release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. 1999; 340 (9): 685–691. DOI: 10.1056/NEJM199903043400903.Jorenby D.E., Leischow S.J., Nides M.A. et al. A controlled trial of sustained- release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. 1999; 340 (9): 685-691. https://doi.org/10.1056/NEJM199903043400903.Faessel H., Ravva P., Williams K. Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebocontrolled, parallel-group study. Clin. Ther. 2009; 31 (1): 177–189. DOI: 10.1016/j.clinthera.2009.01.003.Faessel H., Ravva P., Williams K. Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebocontrolled, parallel-group study. Clin. Ther. 2009; 31 (1): 177-189. https://doi.org/10.1016/j.clinthera.2009.01.003.Willemse B.W.M., Postma D.S., Timens W., ten Hacken N.H.T. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur. Respir. J. 2004; 23 (3): 464–476. DOI: 10.1183/09031936.04.00012704.Willemse B.W.M., Postma D.S., Timens W., ten Hacken N.H.T. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur. Respir. J. 2004; 23 (3): 464-476. https://doi.org/10.1183/09031936.04.00012704.Anthonisen N.R., Connett J.E., Kiley J.P. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1: The Lung Health Study. JAMA. 1994; 272 (19): 1497–1505. DOI: 10.1001/jama.1994.03520190043033.Anthonisen N.R., Connett J.E., Kiley J.P. et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1: The Lung Health Study. JAMA. 1994; 272 (19): 1497-1505. https://doi.org/10.1001/jama.1994.03520190043033.Kardos P., Berck H., Fuchs K.H. et al. Guidelines of the German respiratory society for diagnosis and treatment of adults suffering from acute or chronic cough. Pneumologie. 2010; 64 (11): 701–711. DOI: 10.1055/s-0030-1255526.Kardos P., Berck H., Fuchs K.H. et al. Guidelines of the German respiratory society for diagnosis and treatment of adults suffering from acute or chronic cough. Pneumologie. 2010; 64 (11): 701-711. https://doi.org/10.1055/s-0030-1255526.Kardos P., Dinh Q.T., Fuchs K.H. et al. [Guidelines of the German Respiratory Society for diagnosis and treatment of adults suffering from acute, subacute and chronic cough]. Pneumologie. 2019; 73 (3): 143–180. DOI: 10.1055/a-0808-7409 (in German).Kardos P., Dinh Q.T., Fuchs K.H. et al. [Guidelines of the German Respiratory Society for diagnosis and treatment of adults suffering from acute, subacute and chronic cough]. Pneumologie. 2019; 73 (3): 143-180. https://doi.org/10.1055/a-0808-7409 (in German).Poole P., Black P.N. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2010; (2): CD001287. DOI: 10.1002/14651858.CD001287.pub3.Poole P., Black P.N. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2010; (2): CD001287. https://doi.org/10.1002/14651858.CD001287.pub3.Sevelius H., McCoy J.F., Colmore J.P. Dose response to codeine in patients with chronic cough. Clin. Pharmacol. Ther. 1971; 12 (3): 449–455. DOI: 10.1002/cpt1971123449.Sevelius H., McCoy J.F., Colmore J.P. Dose response to codeine in patients with chronic cough. Clin. Pharmacol. Ther. 1971; 12 (3): 449-455. https://doi.org/10.1002/cpt1971123449.Poole P., Sathananthan K., Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2019; (5): CD001287. DOI: 10.1002/14651858.CD001287.pub6.Poole P., Sathananthan K., Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2019; (5): CD001287. https://doi.org/10.1002/14651858.CD001287.pub6.Melloni B., Germouty J. [The influence of a new beta agonist: formoterol on mucociliary function]. Rev. Mal. Respir. 1992; 9 (5): 503–507 (in French).Melloni B., Germouty J. [The influence of a new beta agonist: formoterol on mucociliary function]. Rev. Mal. Respir. 1992; 9 (5): 503-507 (in French).Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19 (2): 217–224. DOI: 10.1183/09031936.02.00269802.Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19 (2): 217-224. https://doi.org/10.1183/09031936.02.00269802.Cazzola M., Page C. Long-acting bronchodilators in COPD: where are we now and where are we going? Breathe. 2014; 10 (2): 110–120. DOI: 10.1183/20734735.014813.Cazzola M., Page C. Long-acting bronchodilators in COPD: where are we now and where are we going? Breathe. 2014; 10 (2): 110-120. https://doi.org/10.1183/20734735.014813.Ghafouri R., Patil K., Kass I. Sputum changes associated with the use of ipratropium bromide. Chest. 1984; 86 (3): 387–393. DOI: 10.1378/chest.86.3.387.Ghafouri R., Patil K., Kass I. Sputum changes associated with the use of ipratropium bromide. Chest. 1984; 86 (3): 387-393. https://doi.org/10.1378/chest.86.3.387.Ram F., Jones P., Castro A. et al. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2002: 2002 (2): CD003902. DOI: 10.1002/14651858.CD003902.Ram F., Jones P., Castro A. et al. Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2002: 2002 (2): CD003902. https://doi.org/10.1002/14651858.CD003902.Lai K., Shen H., Zhou X. et al. Clinical Practice Guidelines for Diagnosis and Management of Cough-Chinese Thoracic Society (CTS) Asthma Consortium. J. Thorac. Dis. 2018; 10 (11): 6314–6351. DOI: 10.21037/jtd.2018.09.153.Lai K., Shen H., Zhou X. et al. Clinical Practice Guidelines for Diagnosis and Management of Cough-Chinese Thoracic Society (CTS) Asthma Consortium. J. Thorac. Dis. 2018; 10 (11): 6314-6351. https://doi.org/10.21037/jtd.2018.09.153.Staykova T., Black P., Chacko E., Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst. Rev. 2003; (1): CD004105. DOI: 10.1002/14651858.CD004105.Staykova T., Black P., Chacko E., Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst. Rev. 2003; (1): CD004105. https://doi.org/10.1002/14651858.CD004105.El Moussaoui R., Roede B.M., Speelman P. et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008; 63 (5): 415–422. DOI: 10.1136/thx.2007.090613.El Moussaoui R., Roede B.M., Speelman P. et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008; 63 (5): 415-422. https://doi.org/10.1136/thx.2007.090613.Adams S., Luther M. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of chronic obstructive pulmonary disease. Chest. 2000; 117 (5): 1345–1352. DOI: 10.1378/chest.117.5.1345.Adams S., Luther M. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of chronic obstructive pulmonary disease. Chest. 2000; 117 (5): 1345-1352. https://doi.org/10.1378/chest.117.5.1345.Dimopoulos G., Siempos I.I., Korbila I.P. et al. Comparison of first line with secondline antibiotics for acute exacerba tions of chronic bronchitis: a meta-analysis of randomized controlled trials. Chest. 2007; 132 (2): 447–455. DOI: 10.1378/chest.07-0149.Dimopoulos G., Siempos I.I., Korbila I.P. et al. Comparison of first line with secondline antibiotics for acute exacerba tions of chronic bronchitis: a meta-analysis of randomized controlled trials. Chest. 2007; 132 (2): 447-455. https://doi.org/10.1378/chest.07-0149.Giménez M., Aguilar L., Granizo J.J. Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults. Multidiscip. Respir. Med. 2018; 13: 40. DOI: 10.1186/s40248-018-0152-5.Giménez M., Aguilar L., Granizo J.J. Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults. Multidiscip. Respir. Med. 2018; 13: 40. https://doi.org/10.1186/s40248-018-0152-5.Miravitlles M., Espinosa C., Fernandez-Laso E. et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999; 116 (1): 40–46. DOI: 10.1378/chest.116.1.40.Miravitlles M., Espinosa C., Fernandez-Laso E. et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999; 116 (1): 40-46. https://doi.org/10.1378/chest.116.1.40.Синопальников А.И., Зайцев А.А. Антибактериальная терапия при обострении хронической обструктивной болезни легких: фокус на длительность «безынфекционного» периода. Consilium Medicum. 2012; 14 (3): 74–78. Доступно на: https://consilium.orscience.ru/2075-1753/article/view/93587Sinopal’nikov A.I., Zaytsev A.A. [Antibacterial therapy for exacerbation of chronic obstructive pulmonary disease: focus on the duration of the “infection-free”period. Consilium Medicum. 2012; 14 (3): 74-78. Available at: https://consilium.orscience.ru/2075-1753/article/view/93587 (in Russian).Siempos I.I., Dimopoulos G., Korbila I.P. et al. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur. Respir. J. 2007; 29 (6): 1127–1137. DOI: 10.1183/09031936.00147806.Siempos I.I., Dimopoulos G., Korbila I.P. et al. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis. Eur. Respir. J. 2007; 29 (6): 1127-1137. https://doi.org/10.1183/09031936.00147806.Falagas M., Avgeri S., Matthaiou D., Dimopoulos G. Short-versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J. Antimicrob. Chemother. 2008; 62 (3): 442–450. DOI: 10.1093/jac/dkn201.Falagas M., Avgeri S., Matthaiou D., Dimopoulos G. Short-versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J. Antimicrob. Chemother. 2008; 62 (3): 442-450. https://doi.org/10.1093/jac/dkn201.Lorenz J., Steinfeld P., Drath L. et al. Efficacy and tolerability of 5- vs 10-day cefixime therapy in acute exacerbations of chronic bronchitis. Clin. Drug Investig. 1998; 15 (1): 13–20. DOI: 10.2165/00044011-199815010-00002.Lorenz J., Steinfeld P., Drath L. et al. Efficacy and tolerability of 5- vs 10-day cefixime therapy in acute exacerbations of chronic bronchitis. Clin. Drug Investig. 1998; 15 (1): 13-20. https://doi.org/10.2165/00044011-199815010-00002.Синопальников А.И., Зайцев А.А. Комплаентность пациентов с инфекциями дыхательных путей. Клиническая микробиология и антимикробная химиотерапия. 2008; 10 (1): 15–23. Доступно на: https://cmac-journal.ru/publication/2008/1/cmac-2008-t10-n1-p015/Sinopal’nikov A.I., Zaytsev A.A. [Compliance of patients with respiratory tract infections. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2008; 10 (1): 15-23. Available at: https://cmac-journal.ru/publication/2008/1/cmac-2008-t10-n1-p015 (in Russian).Chodosh S., DeAbate C., Haverstock D. et al. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Respir. Med. 2000; 94 (1): 18–27. DOI: 10.1053/rmed.1999.0708.Chodosh S., DeAbate C., Haverstock D. et al. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Respir. Med. 2000; 94 (1): 18-27. https://doi.org/10.1053/rmed.1999.0708.Masterton R., Burley C. Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. Int. J. Antimicrob. Agents. 2001; 18 (6): 503–512. DOI: 10.1016/s0924-8579(01)00435-6.Masterton R., Burley C. Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. Int. J. Antimicrob. Agents. 2001; 18 (6): 503-512. https://doi.org/10.1016/s0924-8579(01)00435-6.Higgings B.G., Powell R.M., Cooper S., Tattersfield A.E. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur. Respir. J. 1991; 4 (4): 415–420. Available at: https://erj.ersjournals.com/content/erj/4/4/415.full.pdfHiggings B.G., Powell R.M., Cooper S., Tattersfield A.E. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur. Respir. J. 1991; 4 (4): 415-420. Available at: https://erj.ersjournals.com/content/erj/4/4/415.full.pdfBerton D.C., Reis M., Siqueira A.C. et al. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD. Respir. Med. 2010; 104 (9): 1288–1296. DOI: 10.1016/j.rmed.2010.05.017.Berton D.C., Reis M., Siqueira A.C. et al. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD. Respir. Med. 2010; 104 (9): 1288-1296. https://doi.org/10.1016/j.rmed.2010.05.017.Tashkin D.P., Donohue J.F., Mahler D.A. et al. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir. Med. 2009; 103 (4): 516–524. DOI: 10.1016/j.rmed.2008.12.014.Tashkin D.P., Donohue J.F., Mahler D.A. et al. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir. Med. 2009; 103 (4): 516-524. https://doi.org/10.1016/j.rmed.2008.12.014.D’Urzo A., Rennard S., Kerwin E. et al. A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease. Respir. Med. 2017; 125: 39–48. DOI: 10.1016/j.rmed.2017.02.008.D’Urzo A., Rennard S., Kerwin E. et al. A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease. Respir. Med. 2017; 125: 39-48. https://doi.org/10.1016/j.rmed.2017.02.008.Pauwels R.A., Buist A.S., Calverley P.M. et al. GOLD scientific committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163 (5): 1256–1276. DOI: 10.1164/ajrccm.163.5.2101039.Pauwels R.A., Buist A.S., Calverley P.M. et al. GOLD scientific committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163 (5): 1256-1276. https://doi.org/10.1164/ajrccm.163.5.2101039.Walters J. A. E. et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014; (9): CD001288. DOI: 10.1002/14651858.CD001288.pub4.Walters J. A. E. et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014; (9): CD001288. https://doi.org/10.1002/14651858.CD001288.pub4.Leuppi J.D., Schuetz P., Bingisser R. et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013; 309 (21): 2223–2231. DOI: 10.1001/jama.2013.5023Leuppi J.D., Schuetz P., Bingisser R. et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013; 309 (21): 2223-2231. https://doi.org/10.1001/jama.2013.5023Niewoehner D.E., Erbland M.L., Deupree R.H. et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N. Engl. J. Med. 1999; 340 (25): 1941–1947. DOI: 10.1056/NEJM199906243402502.Niewoehner D.E., Erbland M.L., Deupree R.H. et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N. Engl. J. Med. 1999; 340 (25): 1941-1947. https://doi.org/10.1056/NEJM199906243402502.Rubin B.K. Mucolytics, expectorants, and mucokinetic medications. Respir. Care. 2007; 52 (7): 859–865. Available at: https://rc.rcjournal.com/content/52/7/859Rubin B.K. Mucolytics, expectorants, and mucokinetic medications. Respir. Care. 2007; 52 (7): 859-865. Available at: https://rc.rcjournal.com/content/52/7/859Avdeev S.N., Vizel A. A., Abrosimo V.N. et al. Management of cough in patients with chronic obstructive pulmonary disease: results of the multicenter randomized placebo-controlled clinical trial. Int. J. Chron. Obstruct. Pulmon. Dis. 2021; 16: 1243–1253. DOI: 10.2147/COPD.S292109.Avdeev S.N., Vizel A. A., Abrosimo V.N. et al. Management of cough in patients with chronic obstructive pulmonary disease: results of the multicenter randomized placebo-controlled clinical trial. Int. J. Chron. Obstruct. Pulmon. Dis. 2021; 16: 1243-1253. https://doi.org/10.2147/COPD.S292109.Зайцев А.А., Оковитый С.В. Кашель: дифференциальный диагноз и рациональная фармакотерапия. Терапевтический архив. 2014; 86 (12): 85–91. Доступно на: https://ter-arkhiv.ru/0040-3660/article/view/31635.Zaytsev A.A., Okovityy S.V. [Cough: differential diagnosis and rational pharmacotherapy. Terapevticheskiy arkhiv. 2014; 86 (12): 85-91. Available at: https://ter-arkhiv.ru/0040-3660/article/view/31635 (in Russian).Nici L., Donner C., Wouters E. et al. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173 (12): 1390–1413. DOI: 10.1164/rccm.200508-1211ST.Nici L., Donner C., Wouters E. et al. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173 (12): 1390-1413. https://doi.org/10.1164/rccm.200508-1211ST.Ries A.L., Bauldoff G.S., Carlin B.W. et al. Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based clinical practice guidelines. Chest. 2007; 131 (5, Suppl.): 4S–42S. DOI: 10.1378/chest.06-2418.Ries A.L., Bauldoff G.S., Carlin B.W. et al. Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based clinical practice guidelines. Chest. 2007; 131 (5, Suppl.): 4S-42S. https://doi.org/10.1378/chest.06-2418.Mahler D.A. Pulmonary rehabilitation. Chest. 1998; 113 (4, Suppl.): 263S–268S. DOI: 10.1378/chest.113.4_supplement.263s.Mahler D.A. Pulmonary rehabilitation. Chest. 1998; 113 (4, Suppl.): 263S-268S. https://doi.org/10.1378/chest.113.4_supplement.263s.Heffner J.E., Fahy B., Hilling L., Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. Am. J. Respir. Crit. Care Med. 1997; 155 (3): 1055–1059. DOI: 10.1164/ajrccm.155.3.9116986.Heffner J.E., Fahy B., Hilling L., Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. Am. J. Respir. Crit. Care Med. 1997; 155 (3): 1055-1059. https://doi.org/10.1164/ajrccm.155.3.9116986.Heffner J.E., Fahy B., Hilling L., Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. Am. J. Respir. Crit. Care Med. 1997; 155 (3): 1055–1059. DOI: 10.1164/ajrccm.155.3.9116986.Heffner J.E., Fahy B., Hilling L., Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. Am. J. Respir. Crit. Care Med. 1997; 155 (3): 1055-1059. https://doi.org/10.1164/ajrccm.155.3.9116986.Гриппозные вакцины: документ по позиции ВОЗ. Еженедельный эпидемиологический бюллетень. 2012, 87 (47): 461– 476.Influenza vaccines: WHO position paper. Ezhenedel’nyy epidemiologicheskiy byulleten’. 2012, 87 (47): 461-476 (in Russian).Grohskopf L.A., Olsen S.J., Sokolow L.Z. et al. Prevention and control of seasonal Influenza with vaccines: recommendations of the advisory committee on immunization practices – United States, 2014–2015. MMWR Morb. Mortal. Wkly Rep. 2014; 63 (32): 691–697. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584910/Grohskopf L.A., Olsen S.J., Sokolow L.Z. et al. Prevention and control of seasonal Influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2014-2015. MMWR Morb. Mortal. Wkly Rep. 2014; 63 (32): 691-697. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584910Moberley S., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; (1): CD000422. DOI: 10.1002/14651858.CD000422.pub3.Moberley S., Holden J., Tatham D.P., Andrews R.M. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; (1): CD000422. https://doi.org/10.1002/14651858.CD000422.pub3.Приказ Министерства здравоохранения Российской Федерации от 15.11.12 № 916н «Об утверждении Порядка оказания медицинской помощи населению по профилю “пульмонология”». Доступно на: https://rg.ru/2013/04/11/legkie-dok.html.Order of the Ministry of Health of the Russian Federation dated November 15, 2012 No.916n “On approval of the procedure for providing medical care to the population in the field of pulmonology”. Available at: https://rg.ru/2013/04/11/legkie-dok.html (in Russian).

The authors declare that there are no conflicts of interest present.